The company purchased Tute in a stock-based transaction that closed last month.
The diagnostics provider said it has paid $250,000 for assets comprised of promissory notes, Series A and Series B stock, and intellectual property.
The deal marks the first software-related acquisition for Agilent since the firm acquired Cartagenia last year.
The acquisition of San Diego-based ValueGene expands IDT's presence in Southern California.
The company said FEI's technology will complement its mass spectrometry business, particularly in its work on structural proteins and biopharmaceuticals.
The acquisition will give India's MedGenome access to a CLIA-certified and CAP-accredited laboratory in the Bay Area so that it can expand its operations in the US.
The genomics company is set to acquire LifebankUSA, which was founded by HLI's own co-founder, from Celgene's Cellular Therapeutics subsidiary.
The UK diagnostics company is selling the subsidiary back to its two cofounders less than two years after buying it.
The Beckman Coulter unit provides genomic sequencing solutions to healthcare businesses, governments, and academia around the world.
The firm also secured a loan commitment from Oberland Capital SA Davos for up to $50 million, which it will use to help fund the acquisition.
In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.
A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.
Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.
Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.